药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ceforanide
Nesiritide
The risk or severity of adverse effects can be increased when Nesiritide is combined with Oxprenolol.
Ceforanide
Amyl Nitrite
The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Oxprenolol.
Ceforanide
Carbetocin
The risk or severity of adverse effects can be increased when Carbetocin is combined with Oxprenolol.
Ceforanide
Diclofenamide
The risk or severity of adverse effects can be increased when Diclofenamide is combined with Oxprenolol.
Ceforanide
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Oxprenolol.
Ceforanide
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Oxprenolol.
Ceforanide
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Oxprenolol.
Ceforanide
Lopinavir
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Oxprenolol.
Ceforanide
Thiothixene
The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Oxprenolol.
Ceforanide
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Oxprenolol.
Ceforanide
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Oxprenolol.
Ceforanide
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Oxprenolol.
Ceforanide
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Oxprenolol.
Ceforanide
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Oxprenolol.
Ceforanide
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Oxprenolol.
Ceforanide
Triclabendazole
The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Oxprenolol.
Ceforanide
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Oxprenolol.
Ceforanide
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Oxprenolol.
Ceforanide
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Oxprenolol.
Ceforanide
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Oxprenolol.